Audio Medica News - Medical News Interviews: Episodes
Audio Journal of Oncology, February 26th, 2008
Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
MARTIN DREYLING, University Hospital Grosshaden, Munich
REFERENCE: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
Since the 1970s therapies for mantle ...
Audio Journal of Oncology, February 26th, 2008
"Total Therapy" Possible Cure For Multiple Myeloma?
BART BARLOGIE, University of Arkansas, Little Rock
REFERENCE: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
A treatment known as "total therapy" could cure many patients ...
Audio Journal of Oncology, February 26th, 2008
Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon
KENNETH ANDERSON, Dana-Farber Cancer Institute, Boston
REFERENCE: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
Multiple myeloma may soon be considered ...
Audio Journal of Medicine, January 11th, 2008
Meta-Analysis Proves Statins Help Patients With Diabetes
COLIN BAIGENT, Oxford University
REFERENCE: Lancet 371:117 January 11, 2008
Statins were foiund to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in ...
Audio Journal of Medicine, January 4th, 2008
Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
PETER TYRER, Imperial College, W6 8RP London
REFERENCE: Lancet 371:57 January 5, 2008
A randomized study comparing treatment with risperidone, ...
Audio Journal of Oncology, December 15th, 2007
Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007
New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
REFERENCE: ABSTRACT 2066
RAD001, a drug targeted at the ...
Audio Journal of Oncology, December 15th, 2007
Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007
ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up
JACK CUZICK, Wolfson Institute of Preventive Medicine, London
REFERENCE: ABSTRACTS 41, 2069, 2071
New data ...
Oncology, December 13th, 2007
Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007
Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
STEPHEN JONES, US Oncology Research, Houston
REFERENCE: ABSTRACT 12
Long term data from an early breast cancer trial ...
Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007
AACR In New Partnership For San Antonio Breast Cancer Symposium
MARGARET FOTI, American Association for Cancer Research, Philadelphia
The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer ...
Audio Journal of Oncology, December 11th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?
CHRISTIAN GEISLER, Rigshospitalet, Copenhagen
REFERENCE: ABSTRACT LB1, ASH 2007
Mantle cell lymphoma, ...
Audio Journal of Oncology, December 10th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Ibritumomab Provides Benefit in Patients with Follicular Lymphoma
ANTON HAGENBEEK, University Medical Centre Utrecht
REFERENCE: ABSTRACT 643, ASH 2007
For patients ...
Audio Journal of Oncology, December 10th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Oblimersen Extends Survival in Chronic Lymphocytic Leukemia
SUSAN O'BRIEN, MD Anderson Cancer Center, Houston
REFERENCE: ASH 2007
For patients with relapsed or refractory ...
Audio Journal of Oncology, December 9th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML
RICHARD STONE, Dana-Farber Cancer Institute, Boston
GEORGE CANELLOS, Dana-Farber Cancer Institute, ...
Audio Journal of Oncology, December 9th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
PIERRE FENAUX, Paris 13 University
REFERENCE: ABSTRACT 817, ASH 2007
Results from a phase III ...
Audio Journal of Oncology, December 9th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Interleukin-2 For Acute Myeloid Leukemia In First Remission?
JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY
GEORGE CANELLOS, Dana-Farber Cancer Institute
REFERENCE: ...
Audio Journal of Oncology, December 8th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
REFERENCE: ...
Audio Journal of Global Health Issues, December 8th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia
ZAKARI ALIYU, Howard University, Washington DC
REFERENCE: Late Breaking Special Session, ...
Audio Journal of Medicine, December 8th, 2007
Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
BENGT ERIKSSON, Gothenburg University
REFERENCE: Abstract 6
In a large phase III trial of patients having ...
Audio Journal of Cardiovascular Medicine, November 6th, 2007
Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
Protective Cardiovascular Benefit for Women on HRT For Natural Menopause
GEORGE SOPKO, National Heart, Lung And Blood Institute, Bethesda, ...
Audio Journal of Cardiovascular Medicine, November 6th, 2007
Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
Oral Contraceptive Use: More Carotid and Femoral Atheroschlerosis Later in Life
ERNST RIETZSCHEL, University of Ghent, Belgium
COMMENT: JENNIFER ...